NYSE (USA) TSX (CANADA)

Directory of Stock Market Company

This site is a directory of Stock Market Company in USA and Canada. Each company page contains a description, stock quote, news and much more. You have also access to the best stock market game on the web.

Search into NYSE and TSX
by quote, company name or key word

facebooktwitterlinkedin
Mail

AHX - Adherex Technologies Inc

Adherex Technologies Inc. (Adherex) is a biopharmaceutical company focused on cancer therapeutics. The Company has two products in the clinical stage of development, including Eniluracil, an oral dihydropyrimidine dehydrogenase (DPD) inhibitor, which improves the tolerability and effectiveness of 5-fluorouracil (5-FU) and STS is a chemoprotectant being developed to reduce or prevent hearing loss that may ","NYSE, Nasdaq, S&P, trading, US market, Asian market, Dow Jones, FTSE, DJIA, DAX, stocks, bonds, shares","Connect to the most current information on stocks and bonds on Reuters.com. What you need to know now about NYSE, Dow Jones, S&P, and Nasdaq at Reuters.com"

AHX Chart

Adherex Technologies Inc News


FDA Advisory Committee Supports Approval of Gilead's Once-Daily Quad Single ...
BioMedReports (subscription) - May 12, 2012
By Staff and Wire Reports Below is a look at some of the headlines for companies that made news in the healthcare sector on May 11, 2012.

Adherex Reports Recent Developments and First Quarter March 31, 2012 Financial ...
Marketwire (press release) - May 11, 2012
RESEARCH TRIANGLE PARK, NORTH CAROLINA--(Marketwire - May 11, 2012) - Adherex Technologies Inc. (TSX:AHX)(PINKSHEETS:ADHXF), a biopharmaceutical company focused on the development of eniluracil and 5-fluorouracil, today reported its financial results ...

Adherex Reports Recent Developments and First Quarter March 31, 2012 Financial ...
MarketWatch (press release) - May 11, 2012
RESEARCH TRIANGLE PARK, NORTH CAROLINA, May 11, 2012 (MARKETWIRE via COMTEX) -- Adherex Technologies Inc. (TOR:CA:AHX) (pinksheets:ADHXF), a biopharmaceutical company focused on the development of eniluracil and 5-fluorouracil, today reported its ...

Adherex Technologies Inc. To Commence Rights Offering
Reuters Key Development - Mar 2, 2011

Adherex Technologies Inc. Changes Record Date for Rights Offering
Reuters Key Development - Feb 22, 2011

Adherex Technologies Inc. Sets Record Date For Rights Offering
Reuters Key Development - Feb 14, 2011

Adherex Technologies Inc. Restatement Of June 30, 2010 Interim Unaudited Consolidated Financial Statements
Reuters Key Development - Nov 1, 2010

Southpoint Announces Holdings In Adherex Technologies Inc.
Reuters Key Development - Sep 1, 2010

TSX Media Coverage Selection of the best articles found in your favorit medias

Next Company >>